Hospital Acquired Infections Market

Global Hospital Acquired infections Market was valued at USD xx million in 2018 and is expected to reach at USD xx million by 2026 at a CAGR of xx% over forecast period 2019-2026.

Global Hospital Acquired infections MarketHospital acquired infections (HAIs) are also referred to as nosocomial infections. In this kind of infections, the patient acquires additional diseases while receiving cure for surgical or medical conditions. HAIs are probable in all settings of care, including surgical centres, hospitals, long-term care facilities such as rehabilitation facilities and nursing homes, and ambulatory clinics. HAIs are more prevalent in developing countries. Certain factors that are driving the market growth include the increase in hospital stay due to chronic diseases and surgeries, rise in the incidences of different types of hospital-acquired infections. Additionally, factor like rise in geriatric population base coupled with demand for hospital-acquired infection diagnostics from middle and low-income economies.

However, factors such as increased microbial resistance, counterfeit and spurious products, off label usage of drugs and antiseptics, increased application of glass and ceramics in building materials, extensive market fragmentation, tough competition, penetration of generics, and loss of patent, are acting as significant restraints to the market growth.

Hospital acquired infections market is segmented by infection type, method of treatment, and pathogen types. By pathogen types, the market is segmented into bacterial, fungal, and viral. Based on treatment method, the market has been segmented into Sterilants, Disinfectants and other products. Based on infection type, the market has been segmented into bloodstream infections, urinary tract infections, gastrointestinal infections, respiratory infections, and surgical site infections.

By geography, Hospital acquired infection is segmented into Europe, North America, APAC, Middle East & Africa, and Latin America. North America is the largest regional segment of the global hospital acquired infection control market. Moreover, the APAC and Latin American regions are expected to witness significant growth over the forecast period. Primarily due to rising incidences of HAIs, growing number of hospitals, increasing medical tourism in emerging countries such as China and India, rising aging population with the resultant increase in the number of chronic disease cases.

The hospital acquired infection market is dominated by major players such as Becton, Dickinson and company, Advanced Sterilization Products, Belimed AG, Getinge AB, Cantel Medical Corp., STERIS Corporation, 3M Company, and others.

The objective of the report is to present comprehensive analysis of Hospital Acquired Infections Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Hospital Acquired Infections Market dynamics, structure by analysing the market segments, and project the global critical communication market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Hospital Acquired Infections Market make the report investor’s guide.

For more information visit: https://www.maximizemarketresearch.com/market-report/hospital-acquired-infections-market/36923/

Scope of the Global Hospital Acquired Infections Market

Global Hospital Acquired Infections Market Segmentation, by Pathogen Types

• Viral

• Bacterial

• Fungal

Hospital Acquired Infections Market Segmentation, by Method of Treatment

• Sterilization

• Chemical

• Radiation

Hospital Acquired Infections Market Segmentation, by Infection Type

• Urinary Tract Infections

• Blood Stream Infections

• Surgical Site Infections

• Gastrointestinal Infections

• Respiratory Infections

Hospital Acquired Infections Market Segmentation, by Region

• North America

• APAC

• Europe

• MEA& Africa

• Latin America

Hospital Acquired Infections Market Major players

• Becton

• Dickinson and Company (U.S.)

• Steris Corporation (U.S.)

• Advanced Sterilization Products

• Getinge Group (Sweden)

• Kimberly-Clark Corporation (U.S.)

• Cantel Medical (U.S.)

• BioMérieux SA (France)

• Belimed AG (Switzerland)

• 3M Company (U.S.)

• Sterigenics International LLC. (U.S.)

• Synergy Health, plc (U.K.)

• Abbott

• Astra Zeneca

• Bayer AG

• Pfizer Inc.

• GlaxoSmithKline plc

• Johnson and Johnson Services, Inc.

• Merck and Co., Inc.

• Cipla Inc.

• Eli Lilly and Company

• Bristol-Myers Squibb Company

• F. Hoffmann-La Roche Ltd.

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: [email protected]

Address : Pune, Maharashtra 411051, India.

Contact: +919607195908

 

[Dhruv Bindhani]

The Global Hospital Acquired Infections (HAIs) Market, also known as nosocomial infections, is a significant segment within healthcare, addressing infections patients acquire during medical or surgical care. This market was valued at USD xx million in 2018 and is projected to reach USD xx million by 2026, growing at a CAGR of xx% over the 2019-2026 forecast period. (Specific values are placeholders for the full report).

HAIs are prevalent across various healthcare settings, including hospitals, surgical centers, long-term care facilities, and ambulatory clinics, and are particularly common in developing countries.

Market Drivers:

The market is driven by several critical factors:

• An increase in hospital stays due to chronic diseases and complex surgeries.
• A rise in the incidence of various types of hospital-acquired infections globally.
• The growing geriatric population which is more susceptible to infections.
• Increasing demand for HAI diagnostics from low and middle-income economies.
• Rising medical tourism in emerging countries like China and India, leading to more hospitalizations.

Market Restraints and Challenges:

Despite the drivers, several factors can hinder market growth:

• Increased microbial resistance to existing treatments.
• Prevalence of counterfeit and spurious products in the market.
• Off-label usage of drugs and antiseptics.
• Increased application of glass and ceramics in building materials, which might pose infection control challenges.
• Extensive market fragmentation and tough competition.
• Penetration of generics and loss of patent protection for key drugs.

Market Segmentation:

The market is comprehensively segmented to provide detailed insights:

• By Infection Type: Bloodstream infections, urinary tract infections, gastrointestinal infections, respiratory infections, and surgical site infections.
• By Method of Treatment: Sterilants, Disinfectants, Chemical, Radiation, and other products/methods.
• By Pathogen Types: Bacterial, fungal, and viral infections.

Regional Outlook:

Geographically, North America is currently the largest regional segment due to advanced healthcare infrastructure and stringent infection control guidelines. However, the APAC (Asia Pacific) and Latin American regions are anticipated to witness significant growth. This growth is primarily attributed to the rising incidences of HAIs, increasing number of hospitals, growing medical tourism, and a rising aging population with associated chronic diseases in these regions.

Competitive Landscape:

The HAI market is dominated by major players focusing on strategic partnerships, mergers, collaborations, and product innovations to expand their portfolios and market presence. Key players include Becton, Dickinson and Company, Advanced Sterilization Products, Belimed AG, Getinge AB, Cantel Medical Corp., STERIS Corporation, and 3M Company. The entry of new companies also signifies a dynamic competitive environment.